# Administrative Core A

> **NIH NIH P50** · DANA-FARBER CANCER INST · 2021 · $1,995,151

## Abstract

Administrative Core 
Abstract 
The purpose of the administrative core is to organize the components of the DF/HCC Spore in Myeloid 
Malignancies and to provide oversight and leadership of the scientific, administrative, and fiscal aspects of this 
SPORE. The SPORE Directors, Dr. Benjamin Ebert and Dr. Richard Stone, will oversee the administrative 
coordination of the various clinical and laboratory studies outlined in this program. They will integrate efforts 
within and between projects and cores thereby promoting rapid movements of findings to benefit patients as 
well as the initiation of laboratory studies stemming from clinical observations. This SPORE infrastructure will 
facilitate critical communication and exchange of data between SPORE leukemia sites to facilitate collaborative 
pre-clinical studies and clinical trials. The administrative core functions will include organization of meetings 
and direction from the external advisory board, internal advisory board, and governance committee. The 
governance committee will be responsible for solicitation, review, and oversight of career development and 
developmental research projects. The administrative core will monitor the progress of the entire SPORE. This 
will include oversight of the projects and cores. The SPORE director will be responsible, in conjunction with 
the governance committee for promotion of developmental projects into translational projects and/or terminate 
a translational project if required. The Core will facilitate the interchange of research information between 
SPOREs within the DF/HCC, guide collaboration and retreats with other leukemia SPOREs, and disseminate 
information about the Clinical Development Awards and Developmental Research Projects within the SPORE 
itself. The Specific Aims of the Administration Core are: 1) to monitor research projects and Cores and plan for 
the future; 2) to foster collaborative research within the SPORE and between SPOREs; 3) to integrate the 
SPORE in Myeloid Leukemias into the DF/HCC structure; 4) to provide necessary resources for fiscal 
oversight; and 5) to promote rapid dissemination of significant research findings.

## Key facts

- **NIH application ID:** 10220871
- **Project number:** 5P50CA206963-06
- **Recipient organization:** DANA-FARBER CANCER INST
- **Principal Investigator:** Benjamin Levine Ebert
- **Activity code:** P50 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $1,995,151
- **Award type:** 5
- **Project period:** 2017-09-19 → 2023-07-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10220871

## Citation

> US National Institutes of Health, RePORTER application 10220871, Administrative Core A (5P50CA206963-06). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10220871. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*